Amplification-Free CRISPR Diagnostics for Point-of-Care Testing
Targets · 06.05.2026 · 4 (2) · 16
DOI: 10.3390/targets4020016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targets, online erschienen am 06.05.2026. Verfasst von Minxiang Li und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
CRISPR-based diagnostics integrated with nucleic acid pre-amplification have demonstrated profound potential for single-molecule detection. However, the pervasive risk of aerosol contamination during amplification significantly hinders their translation to point-of-care testing (POCT). Although amplification-free CRISPR diagnostics promise a streamlined “sample-to-answer” workflow, their development remains in the nascent stages due to the sluggish cleavage kinetics of natural Cas enzymes and the diffusion limitations of trace targets in homogeneous systems. This review systematically summarizes recent core technological advancements, including molecular engineering of CRISPR/Cas systems, novel signal transduction enhancement mechanisms, and digital detection methodologies based on spatial confinement effects. Furthermore, addressing the “matrix effect” that often compromises analytical sensitivity in clinical scenarios, we highlight advanced pre-treatment strategies for complex biological samples. Finally, we propose that the future of POCT relies on the synergy of multiplexed detection, AI-assisted analysis, and microfluidic integration to ultimately bridge the gap between laboratory innovation and clinical application.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- China Postdoctoral Science Foundation
Zitieren
APA
Li, M., Hu, M., & Zhou, X. (2026). Amplification-Free CRISPR Diagnostics for Point-of-Care Testing. Targets, 4(2), 16. https://doi.org/10.3390/targets4020016
Vancouver
Li M, Hu M, Zhou X. Amplification-Free CRISPR Diagnostics for Point-of-Care Testing. Targets. 2026;4(2):16. doi:10.3390/targets4020016
BibTeX
@article{Li2026,
author = {Li, Minxiang and Hu, Menglu and Zhou, Xiaoming},
title = {Amplification-Free CRISPR Diagnostics for Point-of-Care Testing},
journal = {Targets},
year = {2026},
volume = {4},
number = {2},
pages = {16},
doi = {10.3390/targets4020016}
}
EUVIMED